Chikungunya virus and armed forces: relevance and vaccine prospects.
作者信息
Schmidt-Chanasit Jonas, Hagen Ralf Matthias, Frickmann Hagen
机构信息
Department of Arbovirology and Entomology, Bernhard Nocht Institute for Tropical Medicine, 20359, Hamburg, Germany.
Faculty of Mathematics, Informatics and Natural Sciences, Universität Hamburg, 22609, Hamburg, Germany.
出版信息
Eur J Clin Microbiol Infect Dis. 2025 Mar;44(3):763-764. doi: 10.1007/s10096-024-05028-x. Epub 2025 Jan 6.
Abstract
摘要
相似文献
1
Chikungunya virus and armed forces: relevance and vaccine prospects.基孔肯雅病毒与武装部队：相关性及疫苗前景
Eur J Clin Microbiol Infect Dis. 2025 Mar;44(3):763-764. doi: 10.1007/s10096-024-05028-x. Epub 2025 Jan 6.
2
Vaccination policy in Korean armed forces: current status and future challenge.韩国武装部队的疫苗接种政策：现状与未来挑战。
J Korean Med Sci. 2015 Apr;30(4):353-9. doi: 10.3346/jkms.2015.30.4.353. Epub 2015 Mar 19.
3
Chikungunya Virus Infections in Military Deployments in Tropical Settings-A Narrative Minireview.基孔肯雅热病毒感染在热带环境下的军事部署中——一个叙述性的简要综述。
Viruses. 2019 Jun 14;11(6):550. doi: 10.3390/v11060550.
4
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents.减毒活基孔肯雅病毒疫苗在巴西流行地区的安全性和免疫原性：青少年双盲、随机、安慰剂对照3期试验的中期结果
Lancet Infect Dis. 2025 Jan;25(1):114-125. doi: 10.1016/S1473-3099(24)00458-4. Epub 2024 Sep 5.
5
Deployment-related mental health support: comparative analysis of NATO and allied ISAF partners.与部署相关的心理健康支持：北约及其盟军国际安全援助部队伙伴的比较分析。
Eur J Psychotraumatol. 2014 Aug 14;5. doi: 10.3402/ejpt.v5.23732. eCollection 2014.
6
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial.一种单次接种的减毒活寨卡病毒疫苗的安全性和免疫原性：一项双盲、多中心、随机、安慰剂对照、3 期临床试验。
Lancet. 2023 Jun 24;401(10394):2138-2147. doi: 10.1016/S0140-6736(23)00641-4. Epub 2023 Jun 12.
7
A measles virus-based vaccine induces robust chikungunya virus-specific CD4 T-cell responses in a phase II clinical trial.基于麻疹病毒的疫苗在一项 II 期临床试验中诱导出强烈的基孔肯雅病毒特异性 CD4 T 细胞反应。
Vaccine. 2023 Oct 13;41(43):6495-6504. doi: 10.1016/j.vaccine.2023.09.022. Epub 2023 Sep 18.
8
Prevention of infectious diseases during military deployments: a review of the French armed forces strategy.军事部署期间传染病的预防：对法国武装部队战略的回顾。
Travel Med Infect Dis. 2014 Jul-Aug;12(4):330-40. doi: 10.1016/j.tmaid.2014.07.001. Epub 2014 Jul 16.
9
Surveillance of adverse events following vaccination in the French armed forces, 2011-2012.2011 - 2012年法国武装部队疫苗接种后不良事件监测
Public Health. 2015 Jun;129(6):763-8. doi: 10.1016/j.puhe.2015.03.003. Epub 2015 Apr 15.
10
Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates.麻疹病毒载体基孔肯雅疫苗在非人灵长类动物中的免疫原性和功效。
J Infect Dis. 2019 Jul 31;220(5):735-742. doi: 10.1093/infdis/jiz202.
本文引用的文献
1
2
Chikungunya Virus Infections in Military Deployments in Tropical Settings-A Narrative Minireview.基孔肯雅热病毒感染在热带环境下的军事部署中——一个叙述性的简要综述。
Viruses. 2019 Jun 14;11(6):550. doi: 10.3390/v11060550.
3
Chikungunya virus and the global spread of a mosquito-borne disease.基孔肯雅病毒与一种蚊媒疾病的全球传播
N Engl J Med. 2015 Mar 26;372(13):1231-9. doi: 10.1056/NEJMra1406035.
4
Morbidity and impaired quality of life 30 months after chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island.基孔肯雅热感染30个月后的发病率及生活质量受损情况：留尼汪岛法国宪兵队感染与未感染人员的比较队列研究
Medicine (Baltimore). 2012 Jul;91(4):212-219. doi: 10.1097/MD.0b013e318260b604.
Zotero 插件